Loading clinical trials...
Loading clinical trials...
In individuals with obesity, the optimal dosing and duration of venous thromboembolism (VTE) prophylaxis in settings representing acute medical illness or surgery is limited due to lack of randomized ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sanofi
NCT06189313 · Pulmonary Embolism, Acute Pulmonary Embolism, and more
NCT07015905 · Venous Thromboembolism (VTE)
NCT03728166 · Venous Thromboembolism
NCT06393868 · Venous Thromboembolism, Gastro Intestinal Bleeding, and more
NCT07140523 · Venous Thromboembolism
Sanofi U.S.
Bridgewater, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions